Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.

ABSTRACT:

Purpose

To measure the rate of recall of study participation and study attrition in survivors of acute respiratory distress syndrome(ARDS).

Materials/methods

In this ancillary study of the Re-evaluation of Systemic Early neuromuscular blockade(ROSE) trial, we measured the rate of study participation recall 3 months following discharge and subsequent study attrition at 6 months. We compared patient and hospital characteristics, and long-term outcomes by recall. As surrogate decision-makers provided initial consent, we measured the rate of patient reconsent and its association with study recall.

Results

Of 487 patients evaluated, recall status was determined in 386(82.7%). Among these, 287(74.4%) patients recalled participation in the ROSE trial, while 99(25.6%) did not

SUBMITTER: Carlton EF 

PROVIDER: S-EPMC8222163 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature